Head-to-head · WeighScore
CLYR Health vs No BS RX
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 62.2/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.
Before you choose
Before comparing the headline prices, the CLYR Health review and the No BS RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, CLYR Health vs Ro and CoreAge Rx vs No BS RX compare each of them with another graded program, and the list of alternatives to CLYR Health ranks the programs closest to CLYR Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CLYR Health | No BS RX |
|---|---|---|
| WeighScore | 62.2/100 | 82.8/100 |
| Grade | C | B− |
| Site position | #298 | #23 |
| Semaglutide | $169 per 28-day vial (starting dose, compounded; higher doses $199–229) | $149/mo advertised for standard compounded injection; low-dose priced separately |
| Tirzepatide | $149 first month (starting dose, compounded; continuing doses $249–329/month) | $225/mo advertised for standard compounded injection; low-dose priced separately |
| Coverage | Coverage not published | Confirm program availability for your state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #298 · C
Strengths
- Publishes dose-specific single- and two-month purchase totals before intake
- Medication packs include provider review, medication, syringes and shipping
- Terms identify MD Integrations and The Pharmacy Hub as partners
- Optional $99/month ongoing care is separate from one-time medication packs
What to consider
- Tirzepatide starter pricing does not continue at higher doses; semaglutide vials cover 28 days
- Product ineligibility refund promise conflicts with broad nonrefundable terms
- Semaglutide page contains both cold-pack and room-temperature shipping descriptions
- State eligibility and selected-order renewal terms require confirmation
Strengths
- Displays monthly and prepaid amounts by program
- Advertises consultation, medication, shipping and messaging in the compounded plans
- Lists branded Ozempic and Zepbound separately
What to consider
- The $115 headline applies to low-dose programs
- Plans renew automatically at the then-current rate
- Cancellation generally stops future billing without refunding the current period
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.